CAMK2N1 Human

Calcium/Calmodulin Dependent Protein Kinase II Inhibitor 1 Human Recombinant

Recombinant human CAMK2N1 protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 101 amino acids (residues 1-78) with a molecular weight of 10.9 kDa. This protein includes a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT28188
Source
Escherichia Coli.
Appearance
A sterile, colorless solution.

CAMK2N1 Mouse

Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor 1 Mouse Recombinant

Recombinant CAMK2N1 Mouse, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 101 amino acids (1-78 a.a). It has a molecular weight of 10.9 kDa. The protein consists of CAMK2N1 fused to a 23 amino acid His-tag at the N-terminus. Purification is achieved through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT28279
Source
Escherichia Coli.
Appearance
Sterile filtered colorless solution.

CAMK2N2 Human

Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor 2 Human Recombinant

Recombinant human CAMK2N2, expressed in E. coli, is available as a non-glycosylated polypeptide chain. This protein consists of 102 amino acids (including a 23 amino acid His-tag at the N-terminus) and has a molecular weight of 11kDa. Purification is achieved using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT28347
Source
E.coli.
Appearance
The product is a clear, colorless solution that has been sterilized by filtration.

CAMK4 Human

Calcium/Calmodulin-Dependent Protein Kinase IV Human Recombinant

Recombinant CAMK4, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 497 amino acids (1-473) with a molecular weight of 54.5 kDa. This protein features a 24 amino acid His-tag at the N-terminus and undergoes purification through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT28434
Source
E.coli.
Appearance
Clear, colorless solution, sterilized by filtration.
Definition and Classification

Calcium/Calmodulin-Dependent Protein Kinases (CaMKs) are a family of serine/threonine-specific protein kinases regulated by the calcium-binding messenger protein calmodulin. They play crucial roles in translating calcium signals into cellular responses. The CaMK family includes several isoforms, such as CaMK I, II, III, and IV, each with distinct functions and regulatory mechanisms.

Biological Properties

Key Biological Properties: CaMKs are activated by the binding of calmodulin in the presence of calcium ions. This activation leads to autophosphorylation and subsequent phosphorylation of various target proteins.

Expression Patterns: CaMKs are ubiquitously expressed in various tissues, with high expression levels in the brain, heart, and skeletal muscles.

Tissue Distribution:

  • CaMK I: Widely distributed but predominantly found in the brain and nervous system.
  • CaMK II: Highly expressed in the brain, particularly in the hippocampus, and also present in the heart and skeletal muscles.
  • CaMK III: Primarily found in the liver and other metabolic tissues.
  • CaMK IV: Expressed in the brain, thymus, and T-cells.
Biological Functions

Primary Biological Functions: CaMKs are involved in various cellular processes, including gene expression, cell cycle regulation, and synaptic plasticity. They play a pivotal role in learning and memory by modulating synaptic strength.

Role in Immune Responses: CaMKs are implicated in the regulation of immune cell activation and differentiation. For example, CaMK IV is essential for T-cell activation and cytokine production.

Pathogen Recognition: CaMKs contribute to the immune system’s ability to recognize and respond to pathogens by modulating signaling pathways involved in immune responses.

Modes of Action

Mechanisms with Other Molecules and Cells: CaMKs interact with various proteins and cellular structures to exert their effects. They phosphorylate target proteins, leading to changes in their activity, localization, or stability.

Binding Partners: CaMKs bind to calmodulin in a calcium-dependent manner. They also interact with other proteins, such as transcription factors, ion channels, and cytoskeletal proteins.

Downstream Signaling Cascades: Upon activation, CaMKs initiate a cascade of phosphorylation events that propagate the calcium signal. This can lead to the activation of transcription factors, changes in gene expression, and alterations in cellular functions.

Regulatory Mechanisms

Expression and Activity Control: The expression and activity of CaMKs are tightly regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational mechanisms.

Transcriptional Regulation: The expression of CaMK genes is regulated by various transcription factors and signaling pathways. For example, CaMK IV expression is controlled by the cAMP response element-binding protein (CREB).

Post-Translational Modifications: CaMKs undergo several post-translational modifications, such as phosphorylation, ubiquitination, and sumoylation, which modulate their activity, stability, and interactions with other proteins.

Applications

Biomedical Research: CaMKs are extensively studied in the context of neurological disorders, cardiovascular diseases, and cancer. They serve as valuable models for understanding calcium signaling and its implications in health and disease.

Diagnostic Tools: Alterations in CaMK activity or expression can serve as biomarkers for certain diseases. For example, elevated CaMK II activity is associated with cardiac hypertrophy and heart failure.

Therapeutic Strategies: Targeting CaMKs with specific inhibitors or modulators holds potential for treating various conditions, such as neurodegenerative diseases, cardiac disorders, and immune-related diseases.

Role in the Life Cycle

Development: CaMKs play critical roles in embryonic development, particularly in the formation and maturation of the nervous system.

Aging: Changes in CaMK activity are associated with aging-related processes, such as cognitive decline and muscle atrophy.

Disease: Dysregulation of CaMK signaling is implicated in various diseases, including Alzheimer’s disease, Parkinson’s disease, heart failure, and autoimmune disorders.

© Copyright 2024 Thebiotek. All Rights Reserved.